Try Scalarfield FREE for 30 days by going to and using code "SCALARFIRST" at checkout! -------------------------------------- ...

Role-based access controls and restrictions on CLI access on the network are a couple of ways to impose control over ...

Young adults today are digital natives—naturally fluent with devices and online platforms—so some of their most effective ...

Nifty remains under strong bearish pressure after forming consecutive lower highs and lows, with technical indicators ...

If the Nifty 50 sustains below 25,700, a fall below 25,600–25,500 cannot be ruled out in the upcoming sessions; however, ...

Young adults today are digital natives—naturally fluent with devices and online platforms—so some of their most ...

BitMine Immersion Technologies (NYSE: BMNR) acquired 24,266 Ethereum (CRYPTO: ETH) last week, lifting holdings to 4.17 ...

Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency for an extension of ...

EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...

Meta is rated a Strong Buy, with current valuation dislocation driven by accounting noise and misunderstood CapEx cycles.

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...